Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas

NCT00412542 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Glioma

Interventions

DRUG: Thalidomide
DRUG: CPT-11
PROCEDURE: MRI Scan
PROCEDURE: Quantitative Sensory Tests (QST)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]